<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Genvax-Technologies on Bioecon</title><link>https://en.bioecon.ru/companies/genvax-technologies/</link><description>Recent content in Genvax-Technologies on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Thu, 25 Jun 2026 13:45:04 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/genvax-technologies/index.xml" rel="self" type="application/rss+xml"/><item><title>Veterinary biotech &amp; mRNA veterinary drugs</title><link>https://en.bioecon.ru/technology/veterinary-biotech-mrna-drugs/</link><pubDate>Thu, 25 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/veterinary-biotech-mrna-drugs/</guid><description>Advanced veterinary biotechnology focusing on mRNA vaccines, recombinant proteins, and novel biologics to combat zoonotic and livestock diseases with rapid-response platforms.</description></item></channel></rss>